Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
Acta Ophthalmol ; 102(1): 107-115, 2024 Feb.
Article En | MEDLINE | ID: mdl-37231616

PURPOSE: To analyse the effect of exudative age-related macular degeneration (eAMD) lesion components on retinal sensitivity during anti-vascular endothelial growth factor treatment. METHODS: Visual acuity, fluorescein and indocyanine green (ICG) angiographies, autofluorescence images, microperimetries and optical coherence tomographies (OCTs) of 24 eyes of 24 patients were prospectively analysed in a 2-year study of pro-re-nata bevacizumab treatment for eAMD. Microperimetries were aligned with the OCTs, angiographies and autofluorescence images. Thicknesses of the neuroretina, pigment epithelial (RPE) elevation, neuroepithelial detachment (NED), subretinal tissue (SRT) and cystic intraretinal fluid were measured under each stimulus site, and areas of type 1 and type 2 macular neovascularizations (MNVs), ICG plaque, haemorrhage and RPE atrophy were identified. The effects and predictive values of lesion components on retinal sensitivity were analysed with multivariate mixed linear models for repeated measurements. RESULTS: The overall microperimetric retinal sensitivity increased during the first year (from 10.1 dB at baseline to 11.9 dB at 1 year; p = 0.021, Wilcoxon signed ranks), but remained the same during the second year (11.5 dB, p = 0.301). The baseline lesion components most strongly predicting deteriorated sensitivity at 1 year were RPE atrophy, the area of Type 2 MNV, intraretinal cysts, haemorrhage, Type 1 MNV and retinal thickening >350 µm. NED and RPE elevation had only small effects. At 2 years, the predictive values of the baseline lesion components remained quite unchanged. CONCLUSION: The most powerful predictors of retinal sensitivity loss during 2 years of treatment were RPE atrophy, areas of haemorrhage, the area of MNVs, intraretinal cysts and SRT. RPE elevation and NED had lesser effects.


Cysts , Macular Degeneration , Wet Macular Degeneration , Humans , Angiogenesis Inhibitors/therapeutic use , Endothelial Growth Factors , Retinal Pigment Epithelium/pathology , Vascular Endothelial Growth Factor A , Atrophy , Hemorrhage/drug therapy , Hemorrhage/pathology , Macular Degeneration/drug therapy , Tomography, Optical Coherence , Fluorescein Angiography , Wet Macular Degeneration/diagnosis , Wet Macular Degeneration/drug therapy , Wet Macular Degeneration/pathology , Intravitreal Injections
2.
BMC Public Health ; 21(1): 1687, 2021 09 16.
Article En | MEDLINE | ID: mdl-34530777

BACKGROUND: Earlier studies indicate a correlation between disability claims experience and return to work outcomes. Thus, the insurer's role and actions may affect the self-rated health of the disabled worker and the outcomes of occupational rehabilitation. This study diversifies the existing empirical evidence on the role of the insurer in the rehabilitation process and reveals the critical actions that best promote success. MATERIALS AND METHODS: Explorative factor analysis (EFA) and confirmatory factor analysis (CFA), followed by binary regression, were used to analyse survey data of disabled workers (n = 661) who had undergone an occupational rehabilitation within an earnings-related pension insurance system in Finland. RESULTS: The claimant's perceptions of the insurer's (1) high-quality informing and guidance, (2) customer orientation, (3) smooth process flow and (4) positive service attitude had substantial and statistically significant effects on the success of occupational rehabilitation after adjusting for all likely confounding variables. CONCLUSIONS: The insurer's actions are significant predictors of the outcome of occupational rehabilitation. The insurer can promote the health of rehabilitees most effectively by ensuring a smooth process flow and adopting a customer-oriented approach.


Disabled Persons , Insurance Carriers , Cross-Sectional Studies , Humans , Pensions , Return to Work
3.
Disabil Rehabil ; 41(18): 2192-2198, 2019 09.
Article En | MEDLINE | ID: mdl-29688084

Purpose: To study the probabilities and permanence of return to work, inability to work and rehabilitation, and to explore the connection between these life situations and later working after a severe occupational injury. Materials and methods: A historical cohort of Finnish workers with a severe occupational injury during 2008 (N = 11,585) were followed up annually on the outcomes of return to work over a 5-year observation period. We examined transition probabilities from one life situation to another with Markov chain analysis, and applied logistic regression with generalized estimating equations to assess the effect of register-based determinants on return to work. Results: Within the five anniversaries, 85% of the injured were working, 9% were unable to work (fully or partly) and 2% received rehabilitation. Age, gross annual income, type of work, injured body part, injury type and the injured's annual condition subsequent to the work injury were significant determinants of return to work. Conclusions: The probability of return to work decreased with time, but, on average, one-fifth of the injured workers succeeded in return to work after being unable to work on the previous anniversary, which indicates that it is worthwhile to conduct efforts for this target group in order to promote return to work. Implications for Rehabilitation The current life situation of the injured should be taken into account when promoting return to work, as it is a strong predictor of later working after a serious occupational injury. Rehabilitation and return to work programs should start in time due to declining return to work rates as the disability continues. Return to work on a part-time basis could be a good option during the early phases of recovery, since a notable proportion of those partly unable to work on the first anniversary returned later to full-time workers. The probability of recovery is relatively high even for those with long-term disabilities, so the promotion of return to work is highly recommended also for this target group.


Disabled Persons/statistics & numerical data , Life Change Events , Occupational Injuries/epidemiology , Return to Work/statistics & numerical data , Adolescent , Adult , Age Factors , Aged , Cohort Studies , Disabled Persons/rehabilitation , Female , Finland/epidemiology , Humans , Income , Injury Severity Score , Male , Middle Aged , Occupational Injuries/rehabilitation , Registries , Retirement/statistics & numerical data , Unemployment/statistics & numerical data , Young Adult
4.
Autism Res ; 10(5): 810-820, 2017 May.
Article En | MEDLINE | ID: mdl-28244277

Reduced use of eye contact is a prominent feature in individuals with autism spectrum disorder (ASD). It has been proposed that direct gaze does not capture the attention of individuals with ASD. Experimental evidence is, however, mainly restricted to relatively high-functioning school-aged children or adults with ASD. This study investigated whether 2-5-year-old low-functioning children with severe ASD differ from control children in orienting to gaze stimuli, as measured with the heart rate deceleration response. Responses were measured to computerized presentations of dynamic shifts of gaze direction either toward (direct) or away (averted) from the observing child. The results showed a significant group by gaze direction interaction effect on heart rate responses (permuted P = .004), reflecting a stronger orienting response to direct versus averted gaze in typically developing (N = 17) and developmentally delayed (N = 16) children but not in children with ASD (N = 12). The lack of enhanced orienting response to direct gaze in the ASD group was not caused by a lack of looking at the eye region, as confirmed by eye tracking. The results suggest that direct gaze is not a socially salient, attention-grabbing signal for low-functioning children with ASD. Autism Res 2017, 10: 810-820. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.


Arousal/physiology , Attention/physiology , Autism Spectrum Disorder/physiopathology , Developmental Disabilities/physiopathology , Fixation, Ocular/physiology , Interpersonal Relations , Orientation/physiology , Affect/physiology , Autism Spectrum Disorder/diagnosis , Autism Spectrum Disorder/psychology , Child, Preschool , Developmental Disabilities/diagnosis , Developmental Disabilities/psychology , Female , Heart Rate/physiology , Humans , Male , Nonverbal Communication/physiology , Nonverbal Communication/psychology
5.
Retina ; 36(11): 2183-2190, 2016 Nov.
Article En | MEDLINE | ID: mdl-27135211

PURPOSE: To study the anterior chamber flare during bevacizumab treatment of exudative age-related macular degeneration. METHODS: During a 2-year prospective follow-up, 50 patients recently diagnosed with exudative age-related macular degeneration were treated at once-a-month visits if subretinal or intraretinal fluid or a new hemorrhage was present in the lesion area. Flare was measured weekly during the first month and then monthly in both eyes. RESULTS: Higher flare was associated with older age (P = 0.007, Linear Mixed Model), higher number of smoking pack-years (P = 0.019), macular cysts (P = 0.041), and pseudophakia (P = 0.003). The levels gradually increased during the follow-up (P < 0.0001) but less in the eyes with classic CNV (P = 0.011). Flare decreased during treatment-free periods lasting for at least two consecutive visits (P = 0.005). A peak in flare was observed 1 week after the first injection (P = 0.034, Wilcoxon signed rank test). In the fellow eyes, higher flare values in the beginning of the follow-up were associated with later conversion into exudative age-related macular degeneration (P = 0.015, Mann-Whitney U test). CONCLUSION: Anterior chamber flare correlated poorly with the CNV activity. Higher levels may, however, precede or exist early in the process that leads to the development of exudative age-related macular degeneration.


Angiogenesis Inhibitors/therapeutic use , Anterior Chamber/pathology , Bevacizumab/therapeutic use , Subretinal Fluid , Uveitis, Anterior/physiopathology , Wet Macular Degeneration/drug therapy , Aged , Exudates and Transudates , Female , Fluorescein Angiography , Follow-Up Studies , Humans , Intravitreal Injections , Male , Photometry , Prospective Studies , Tomography, Optical Coherence , Uveitis, Anterior/diagnosis , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Visual Acuity/physiology , Wet Macular Degeneration/diagnosis , Wet Macular Degeneration/physiopathology
...